Literature DB >> 18456782

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

R Dummer1, A Hauschild, L Jost.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456782     DOI： 10.1093/annonc/mdn100

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

2.  Plasma markers for identifying patients with metastatic melanoma.

Authors:  Harriet M Kluger; Kathleen Hoyt; Antonella Bacchiocchi; Tina Mayer; Jonathan Kirsch; Yuval Kluger; Mario Sznol; Stephan Ariyan; Annette Molinaro; Ruth Halaban
Journal:  Clin Cancer Res       Date:  2011-04-12       Impact factor: 12.531

3.  MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

Authors:  J C Hassel; A Sucker; L Edler; H Kurzen; I Moll; C Stresemann; K Spieth; C Mauch; K Rass; R Dummer; D Schadendorf
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

4.  Trends in cancer immunotherapy.

Authors:  Joseph F Murphy
Journal:  Clin Med Insights Oncol       Date:  2010-07-14

5.  Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.

Authors:  Enrico P Spugnini; Annamaria Biroccio; Roberta De Mori; Marco Scarsella; Carmen D'Angelo; Alfonso Baldi; Carlo Leonetti
Journal:  J Transl Med       Date:  2011-07-28       Impact factor: 5.531

6.  Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).

Authors:  Grant A McArthur; Peter Mohr; Paolo Antonio Ascierto; Ana Arance; Ana Banos Hernaez; Peter Kaskel; Michael Weichenthal; Reshma Shinde; Kendall Stevinson
Journal:  Oncologist       Date:  2017-05-19

7.  Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

Authors:  A Hauschild
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.